Among these biomarkers, the Ki-67 index is a well-defined indicator for tumor proliferation and can be used as a prognostic factor for early breast cancer, particularly in those with HR+/HER2− diseases (12–14). The gene discussed is ERBB2; the disease is breast carcinoma.